Nervous System Channel
Topics
Medications
Quicklinks
Related Channels

Carbidopa-Levodopa-Entacapone Info

The U.S. Food and Drug Administration (FDA) has approved carbidopa-levodopa-entacapone (Stalevo®) to treat Parkinson's disease in the following situations:
 
  • As a substitution for carbidopa-levodopa (Sinemet®) plus entacapone (Comtan®) in people already taking these medications
  •  
  • As a replacement for carbidopa-levodopa in people experiencing "wearing-off" symptoms who take 600 mg of levodopa per day or less and who are not experiencing dyskinesia (a movement disorder that is a side effect of carbidopa-levodopa).
  •  
Prior to prescribing carbidopa-levodopa-entacapone, your healthcare provider needs information on your complete medical history and any other drugs you are taking. This will help ensure a safe, effective treatment process.
 
(Click Carbidopa-Levodopa-Entacapone for more information, including how this medication works, side effects to be aware of, and general dosing guidelines.)
 

Carbidopa-Levodopa-Entacapone Info

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.